These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39125348)

  • 1. The Association between Body Composition Phenotype and Insulin Resistance in Post-COVID-19 Syndrome Patients without Diabetes: A Cross-Sectional, Single-Center Study.
    González-Islas D; Flores-Cisneros L; Orea-Tejeda A; Keirns-Davis C; Hernández-López N; Arcos-Pacheco LP; Zurita-Sandoval A; Albarran-López F; García-Castañeda L; Salgado-Fernández F; Hernández-López S; Jiménez-Valentín A; Pérez-García I
    Nutrients; 2024 Jul; 16(15):. PubMed ID: 39125348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynapenia and Sarcopenia in Post-COVID-19 Syndrome Hospitalized Patients Are Associated with Severe Reduction in Pulmonary Function.
    Orea-Tejeda A; Robles-Hernández R; González-Islas D; Jimenez-Gallardo L; Gochicoa-Rangel L; Castorena-Maldonado A; Hernández-Zenteno R; Montañez-Orozco A; Valderrábano-Salas B
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition and risk factors associated with sarcopenia in post-COVID patients after moderate or severe COVID-19 infections.
    González-Islas D; Sánchez-Moreno C; Orea-Tejeda A; Hernández-López S; Salgado-Fernández F; Keirns-Davis C; Galicia-Amor S; Trejo-Mellado E; Gochicoa-Rangel L; Castorena-Maldonado A
    BMC Pulm Med; 2022 Jun; 22(1):223. PubMed ID: 35676657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19.
    Pérez-Campos Mayoral L; Matias-Cervantes CA; Pérez-Campos E; Romero Díaz C; Laguna Barrios LÁ; Pina Canseco MDS; Martínez Cruz M; Pérez-Campos Mayoral E; Solórzano Mata CJ; Rodal Canales FJ; Martínez Ruíz H; Hernández-Huerta MT
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worsening Disability and Hospitalization Risk in Sarcopenic Obese and Dynapenic Abdominal Obese: A 5.5 Years Follow-Up Study in Elderly Men and Women.
    Rossi AP; Urbani S; Fantin F; Nori N; Brandimarte P; Martini A; Zoico E; Mazzali G; Babbanini A; Muollo V; Zamboni M
    Front Endocrinol (Lausanne); 2020; 11():314. PubMed ID: 32695067
    [No Abstract]   [Full Text] [Related]  

  • 6. Obesity phenotypes are, in part, associated with physical activity in diabetic hemodialysis patients.
    de Oliveira Matos B; da Costa Rosa CS; Ribeiro HS; Marcos NM; Losilla MPR; Monteiro HL; Gimenes C
    Int Urol Nephrol; 2022 Jul; 54(7):1751-1759. PubMed ID: 34816362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures Over 5-10 Years in Community-Dwelling Older Adults.
    Scott D; Chandrasekara SD; Laslett LL; Cicuttini F; Ebeling PR; Jones G
    Calcif Tissue Int; 2016 Jul; 99(1):30-42. PubMed ID: 26939775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity.
    Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Di Martino M; Catalano C; Lenzi A; Donini LM
    Clin Nutr; 2019 Oct; 38(5):2430-2435. PubMed ID: 30792144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Sarcopenia and Dynapenia and Related Clinical Outcomes in Patients with Type 1 Diabetes Mellitus.
    Andreo-López MC; Zarco-Martín MT; Contreras-Bolívar V; Fernández-Soto ML
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.
    Levine ME; Crimmins EM
    Obesity (Silver Spring); 2012 Oct; 20(10):2101-6. PubMed ID: 22310233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
    Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
    Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Sarcopenia in Outpatients with Post-Critical SARS-CoV2 Disease. Nutritional Ultrasound of Rectus Femoris Muscle, a Potential Tool.
    Cornejo-Pareja I; Soler-Beunza AG; Vegas-Aguilar IM; Fernández-Jiménez R; Tinahones FJ; García-Almeida JM
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults.
    Scott D; Sanders KM; Aitken D; Hayes A; Ebeling PR; Jones G
    Obesity (Silver Spring); 2014 Jun; 22(6):1568-74. PubMed ID: 24585708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive impact of obesity on the prognosis of liver cirrhosis.
    Endo K; Kakisaka K; Abe T; Yusa K; Nakaya I; Watanabe T; Suzuki A; Yoshida Y; Oikawa T; Miyasaka A; Kuroda H; Matsumoto T
    J Gastroenterol Hepatol; 2024 Aug; 39(8):1663-1672. PubMed ID: 38700075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
    Batsis JA; Mackenzie TA; Jones JD; Lopez-Jimenez F; Bartels SJ
    Clin Nutr; 2016 Dec; 35(6):1472-1483. PubMed ID: 27091774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity, dynapenia, and their combination: Implications for bone mineral density in Brazilian adults-the Pró-Saúde study.
    Chain A; Faerstein E; Wahrlich V; Bezerra FF
    Nutrition; 2021 Jan; 81():110898. PubMed ID: 32739661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
    Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.
    Srikanthan P; Hevener AL; Karlamangla AS
    PLoS One; 2010 May; 5(5):e10805. PubMed ID: 22421977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynapenic obesity as an associated factor to lipid and glucose metabolism disorders and metabolic syndrome in older adults - Findings from SABE Study.
    Alexandre TDS; Aubertin-Leheudre M; Carvalho LP; Máximo RO; Corona LP; Brito TRP; Nunes DP; Santos JLF; Duarte YAO; Lebrão ML
    Clin Nutr; 2018 Aug; 37(4):1360-1366. PubMed ID: 28647293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study.
    Mori H; Kuroda A; Yoshida S; Yasuda T; Umayahara Y; Shimizu S; Ryomoto K; Yoshiuchi K; Yamamoto T; Matsuoka TA; Shimomura I; Matsuhisa M
    J Diabetes Investig; 2021 Jun; 12(6):1050-1059. PubMed ID: 33063949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.